Clinical Trial Detail

NCT ID NCT02834403
Title L-NMMA Plus Taxane Chemotherapy in Refractory Locally Advanced or Metastatic Triple Negative Breast Cancer Patients
Recruitment Recruiting
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors Polly A. Niravath, MD
Indications

triple-receptor negative breast cancer

Therapies

Pegfilgrastim

Docetaxel + L-NMMA

Age Groups: adult senior

No variant requirements are available.